Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Observational ajmaline provocation study in healthy subjects
2016-004277-41Phase 2Completed
- Sponsor
- St George's, University of London
- Start
- Aug 2020
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of ajmaline, sponsored by St George's, University of London. Primary endpoint: Electrocardiographic response to ajmaline. Started Aug 2020; status: completed.
02
Drugs
ajmaline
Beyond the preview
Go deeper on 2016-004277-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-004277-41.